The Heme Oxygenase-1 gene promoter polymorphism is associated to outcome in patients receiving HLA-identical sibling allogeneic peripheral blood stem-cell transplantation (Allo-PBSCT) with reduced intensity conditioning (RIC)

被引：0
|
作者：
Alcoceba, M. [1 ]
Garcia-Alvarez, M. [1 ]
Lopez-Godino, O. [1 ]
Lopez-Corral, L. [1 ]
Garcia-Guerrero, E. [2 ]
Ferre, O. [1 ]
Balanzategui, A. [1 ]
Valcarcel, D. [3 ]
Castilla, C. [4 ]
Heras, I. [4 ]
Esquirol, A. [5 ]
Martino, R. [5 ]
Perez-Simon, J. A. [2 ]
Marin, L. [1 ]
Garcia-Sanz, R. [1 ]
Gonzalez, M. [1 ]
Caballero, M. D. [1 ]
机构：
[1] Hosp Univ Salamanca CAUSA IBSAL, Dept Hematol, Salamanca, Spain
[2] Hosp Univ Virgen del Rocio IBIS, Dept Hematol, Seville, Spain
[3] Hosp Univ Vall dHebron, Dept Hematol, Barcelona, Spain
[4] Hosp Gen Univ Morales Meseguer, Dept Hematol, Murcia, Spain
[5] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P102
引用
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [41] Outcome After 9/10 Mismatched Unrelated Donor or Cord Blood Cells Allogeneic Stem Cell Transplantation (allo-SCT) in the Setting of Reduced-Intensity Conditioning (RIC)
    Malard, Florent
    Furst, Sabine
    Loirat, Marion
    Chevallier, Patrice
    El-Cheikh, Jean
    Guillaume, Thierry
    Delaunay, Jacques
    Legouill, Steven
    Moreau, Philippe
    Blaise, Didier
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [42] Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    Pérez-Simón, JA
    Díez-Campelo, M
    Martino, R
    Sureda, A
    Caballero, D
    Cañizo, C
    Brunet, S
    Altes, A
    Vazquez, L
    Sierra, J
    San Miguel, JF
    BLOOD, 2003, 102 (03) : 1108 - 1113
  • [43] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute lymphoblastic leukemia (ALL): A survey from the European group for blood and marrow transplantation (EBMT).
    Mohty, M
    Labopin, M
    Boiron, JM
    Theorin, N
    Fauser, A
    Rambaldi, A
    Boogaerts, M
    Slavin, S
    Majolino, I
    Blaise, D
    Rocha, V
    BLOOD, 2005, 106 (11) : 195A - 195A
  • [44] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS RECEIVING A FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING (RIC) AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION (allo-HSCT)
    Detrait, M.
    Chevallier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Ducastelle, S.
    Chelghoum, Y.
    Barraco, F.
    Labussiere, H.
    Mohty, M.
    Michallet, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S335 - S336
  • [45] Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
    Baron, F.
    Labopin, M.
    Blaise, D.
    Lopez-Corral, L.
    Vigouroux, S.
    Craddock, C.
    Attal, M.
    Jindra, P.
    Goker, H.
    Socie, G.
    Chevallier, P.
    Browne, P.
    Sandstedt, A.
    Duarte, R. F.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 (03) : 389 - 396
  • [46] Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)
    Detrait, Marie Y.
    Chevallier, Patrice
    Sobh, Mohamad
    Guillaume, Thierry
    Thomas, Xavier
    Morisset, Stephane
    Tedone, Nathalie
    Delaunay, Jacques
    Nicolini, Franck E.
    Labussiere, Helene
    Ducastelle, Sophie
    Fattoum, Jihane
    Barraco, Fiorenza
    Cannas, Giovanna
    Chelghoum, Youcef
    Mohty, Mohamad
    Michallet, Mauricette
    BLOOD, 2011, 118 (21) : 853 - 854
  • [47] Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
    F Baron
    M Labopin
    D Blaise
    L Lopez-Corral
    S Vigouroux
    C Craddock
    M Attal
    P Jindra
    H Goker
    G Socié
    P Chevallier
    P Browne
    A Sandstedt
    R F Duarte
    A Nagler
    M Mohty
    Bone Marrow Transplantation, 2014, 49 : 389 - 396
  • [48] The Role of In Vivo T-Cell Depletion On Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation From HLA-Identical Siblings in Patients with Follicular Lymphoma: An European Blood and Marrow Transplantation Study
    Delgado, Julio
    Canals, Carme
    Attal, Michel
    Thomson, Kirsty
    Campos, Antonio
    Martino, Rodrigo
    Littlewood, Timothy James
    Jackson, Graham H.
    Milpied, Noel-Jean
    Maertens, Johann
    Hunter, Ann E.
    Janssen, Jeroen J. W. M.
    Montoto, Silvia
    Sureda, Anna
    BLOOD, 2009, 114 (22) : 1310 - 1310
  • [49] REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES: COMPARABLE OUTCOMES WITH UNRELATED UMBILICAL CORD BLOOD AND HLA-IDENTICAL SIBLING DONORS
    Majbail, N. S.
    Brunstein, C. G.
    Warlick, E. D.
    Oran, B.
    Shanley, R.
    Sandhu, K. S.
    Wagner, J. E.
    Weisdorf, D. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S155 - S155
  • [50] Allogeneic bone marrow transplantation (BMT) without ATG versus allogeneic peripheral blood stem cell transplantation (PBSCT) with ATG in AML patients given grafts from HLA-identical siblings: a retrospective study by the ALWP of the EBMT
    Baron, F.
    Beohou, E.
    Labopin, M.
    Aljurf, M.
    Hamladji, R-M
    Wu, D.
    Stelljes, M.
    Yakoub-Agha, I.
    Stuhler, G.
    van Lint, M. T.
    Fegueux, N.
    Othman, T. B.
    Blaise, D.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S32 - S32
12345